FDA Inspection
Eurofins Lancaster Laboratories, IncEurofins Lancaster Laboratories, Inc – FDA Inspection, Aug 26, 2025
Record Details
This FDA Inspection record concerns Eurofins Lancaster Laboratories, Inc, with an inspection on August 26, 2025, issued by the Philadelphia District Office, covering human drugs.
View Company Profile
ID · 204a3e19-1058-4e10-b09a-d0d509c4df22
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1279557
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.165(b)Microbiological testing
- 21 CFR 211.192Written record of investigation incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Eurofins Lancaster Laboratories, Inc
13| Date | Classification | Office | Project area |
|---|---|---|---|
| September 23, 2025 | Not classified | Philadelphia District Office | |
| October 21, 2021 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 17, 2019 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| September 13, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 19, 2017 | Not classified | Philadelphia District Office |
Other documents for Eurofins Lancaster Laboratories, Inc
- FDA Inspection 1284580 - 2025-09-23
- FDA Inspection 1156933 - 2021-10-21
- FDA Inspection 1113269 - 2019-10-17
- FDA Inspection 1106449 - 2019-09-13
- FDA Inspection 1031761 - 2017-10-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.